A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
- Cecilia Monge
- , Erica C. Pehrsson
- , Changqing Xie
- , Austin G. Duffy
- , Donna Mabry
- , Bradford J. Wood
- , David E. Kleiner
- , Seth M. Steinberg
- , William D. Figg
- , Bernadette Redd
- , Anuradha Budhu
- , Sophie Wang
- , Mayank Tandon
- , Lichun Ma
- , Xin Wei Wang
- , Tim F. Greten*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations